Literature DB >> 28971440

Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry.

Richard Y-C Huang1, Roxana E Iacob2, Sethu Sankaranarayanan3, Ling Yang3, Michael Ahlijanian3, Li Tao4, Adrienne A Tymiak1, Guodong Chen5.   

Abstract

Fibrillization of the microtubule-associated protein tau has been recognized as one of the signature pathologies of the nervous system in Alzheimer's disease, progressive supranuclear palsy, and other tauopathies. The conformational transition of tau in the fibrillization process, tau monomer to soluble aggregates to fibrils in particular, remains unclear. Here we report on the use of hydrogen/deuterium exchange mass spectrometry (HDX-MS) in combination with other biochemical approaches, including Thioflavin S fluorescence measurements, enzyme-linked immunosorbent assay (ELISA), and Western blotting to understand the heparin-induced tau's fibrillization. HDX-MS studies including anti-tau antibody epitope mapping experiments provided molecular level details of the full-length tau's conformational dynamics and its regional solvent accessibility upon soluble aggregates formation. The results demonstrate that R3 region in the full-length tau's microtubule binding repeat region (MTBR) is stabilized in the aggregation process, leaving both N and C terminal regions to be solvent exposed in the soluble aggregates and fibrils. The findings also illustrate the practical utility of orthogonal analytical methodologies for the characterization of protein higher order structure. Graphical Abstract ᅟ.

Entities:  

Keywords:  Epitope mapping; Fibrillization; Hydrogen/deuterium exchange; Mass spectrometry; tau

Mesh:

Substances:

Year:  2017        PMID: 28971440     DOI: 10.1007/s13361-017-1815-8

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  36 in total

1.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors:  Damian Houde; Steven A Berkowitz; John R Engen
Journal:  J Pharm Sci       Date:  2010-12-29       Impact factor: 3.534

2.  Assessment of the repeatability and reproducibility of hydrogen/deuterium exchange mass spectrometry measurements.

Authors:  William Burkitt; Gavin O'Connor
Journal:  Rapid Commun Mass Spectrom       Date:  2008-12       Impact factor: 2.419

3.  Predictive atomic resolution descriptions of intrinsically disordered hTau40 and α-synuclein in solution from NMR and small angle scattering.

Authors:  Martin Schwalbe; Valéry Ozenne; Stefan Bibow; Mariusz Jaremko; Lukasz Jaremko; Michal Gajda; Malene Ringkjøbing Jensen; Jacek Biernat; Stefan Becker; Eckhard Mandelkow; Markus Zweckstetter; Martin Blackledge
Journal:  Structure       Date:  2013-12-19       Impact factor: 5.006

4.  Time window expansion for HDX analysis of an intrinsically disordered protein.

Authors:  Devrishi Goswami; Srikripa Devarakonda; Michael J Chalmers; Bruce D Pascal; Bruce M Spiegelman; Patrick R Griffin
Journal:  J Am Soc Mass Spectrom       Date:  2013-07-25       Impact factor: 3.109

Review 5.  Hydrogen exchange mass spectrometry: are we out of the quicksand?

Authors:  Roxana E Iacob; John R Engen
Journal:  J Am Soc Mass Spectrom       Date:  2012-04-03       Impact factor: 3.109

6.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

Review 7.  Molecular mechanism of prion-like tau-induced neurodegeneration.

Authors:  Alejandra D Alonso; Cindy Beharry; Christopher P Corbo; Leah S Cohen
Journal:  Alzheimers Dement       Date:  2016-04-25       Impact factor: 21.566

Review 8.  Tau and tauopathies.

Authors:  Thomas Arendt; Jens T Stieler; Max Holzer
Journal:  Brain Res Bull       Date:  2016-09-09       Impact factor: 4.077

9.  Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation.

Authors:  Alba Espargaró; Raimon Sabate; Salvador Ventura
Journal:  Mol Biosyst       Date:  2012-08-07

10.  Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.

Authors:  Jere E Meredith; Sethu Sankaranarayanan; Valerie Guss; Anthony J Lanzetti; Flora Berisha; Robert J Neely; J Randall Slemmon; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Holly Soares; Michael Ahlijanian; Charles F Albright
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

View more
  9 in total

1.  Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Richard Y-C Huang; Steven R O'Neil; Daša Lipovšek; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2018-05-07       Impact factor: 3.109

Review 2.  Research advances in hydrogen-deuterium exchange mass spectrometry for protein epitope mapping.

Authors:  Haofeng Sun; Lingyun Ma; Leyu Wang; Peng Xiao; Hongmei Li; Min Zhou; Dewei Song
Journal:  Anal Bioanal Chem       Date:  2021-01-06       Impact factor: 4.142

3.  Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-Based Hydrogen-Deuterium Exchange, Cross-linking, and Molecular Docking.

Authors:  Mengru Mira Zhang; Richard Y-C Huang; Brett R Beno; Ekaterina G Deyanova; Jing Li; Guodong Chen; Michael L Gross
Journal:  Anal Chem       Date:  2020-06-10       Impact factor: 6.986

4.  The role of wild-type tau in Alzheimer's disease and related tauopathies.

Authors:  Chih Hung Lo; Jonathan N Sachs
Journal:  J Life Sci (Westlake Village)       Date:  2020-12

5.  Epitope Mapping with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry.

Authors:  Catherine Y Tremblay; Zachary J Kirsch; Richard W Vachet
Journal:  Anal Chem       Date:  2021-12-21       Impact factor: 8.008

Review 6.  Applications of Mass Spectrometry in the Onset of Amyloid Fibril Formation: Focus on the Analysis of Early-Stage Oligomers.

Authors:  Jiaojiao Hu; Qiuling Zheng
Journal:  Front Chem       Date:  2020-05-05       Impact factor: 5.221

Review 7.  Advances and considerations in AD tau-targeted immunotherapy.

Authors:  Alice Bittar; Nemil Bhatt; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2019-12-10       Impact factor: 5.996

Review 8.  Neurodegenerative Proteinopathies in the Proteoform Spectrum-Tools and Challenges.

Authors:  Aneeqa Noor; Saima Zafar; Inga Zerr
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

9.  Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies.

Authors:  Chih Hung Lo; Colin Kin-Wye Lim; Zhipeng Ding; Sanjula P Wickramasinghe; Anthony R Braun; Karen H Ashe; Elizabeth Rhoades; David D Thomas; Jonathan N Sachs
Journal:  Alzheimers Dement       Date:  2019-10-22       Impact factor: 21.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.